Proposed medicine price controls are estimated to result in a loss of about RM8 billion to Malaysia’s medical tourism industry by 2037, according to a cost-benefit analysis.
The Malaysia Healthcare Travel Council’s efforts to forge resilience in the medical tourism industry include regional cross collaborations and a five-year industry blueprint to propel Malaysia as the leading global destination for health care.
Health Minister Dr Adham Baba says commitment to provide the best in clinical and service excellence has pushed Malaysia to become Asia’s cardiology hub.